This paper is an attempt to unpack the emergence and dynamics of science-based technologies in conceptual forms that allow us to understand better when and how the social and economic organization of search and problem-solving matters. The evolution over two decades of a specific science-based...

This book offers a novel insight into the economic dynamics of modern biotechnology, using examples from Europe to reflect global trends. The authors apply theoretical insight to a fundamental enigma of the modern learning society, namely, how and why the development of knowledge and ideas...

This paper examines the re-combinatorial capacity (RCC) of regional high-tech economies. Empirically the paper studies the emergence and development of new firms derived in various forms from a downsizing lead pharmaceutical firm (Pharmacia). A model is developed conceptualizing RCC of regions...

Several recent studies show European university scientists contributing far more frequently to company-owned patented inventions than they do to patents owned by universities or by the academic scientists themselves. Recognising the significance of this channel for direct commercialisation of...

Although biotech start-ups fail or succeed based on their research few attempts have been made to examine if and how they strategize in this core of their activity. Popular views on Dedicated Biotech Firms (DBFs) see the inherent uncertainty of research as defying notions of strategizing,...

Mapping the emergence of clusters of biotech firms specializing in drug discovery in Denmark and Sweden from 1997 to 2004 we find that Denmark faster and to a higher extent concentrated activities in the mid-sized categories of firms and also earlier and more steeply increased key outputs such...